Publications

• Atypical Intramucosal Melanocytic Cell Proliferation in Colorectal Mucosa
  Volume: 150 Page(s): S17 - S17
  10/01/2018 Authors: Zhang B; Strauss R; Moran A; Zhang P; Xu X
• A Memorial Tribute to Horacio Jinich.
  Gastroenterology Volume: 154 Page(s): 2009 - 2011
  06/01/2018 Authors: Strauss RM; Hersh T
• A Phase 2B, Multicenter, Randomized, Placebo-Controlled Dose-Ranging Trial of Peficitinib, an Oral JAK Inhibitor, in Patients with Moderately-Severely Active UC
  Volume: 23 Page(s): S8 - S8
  02/01/2017 Authors: Sands B; Sandborn W; Feagan B; Lichtenstein G; Zhang H; Szapary P; Panes J; Vermeire S; Christopher OOB; Dewey J
• Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
  Gastroenterology Volume: 145 Page(s): 1035 - 1044.e5
  11/01/2013 Authors: Poordad F; Lawitz E; Reddy KR; Afdhal NH; Hzode C; Zeuzem S; Lee SS; Calleja JL; Brown RS; Craxi A
• Boceprevir for untreated chronic HCV genotype 1 infection.
  N Engl J Med Volume: 364 Page(s): 1195 - 1206
  03/31/2011 Authors: Poordad F; McCone J; Bacon BR; Bruno S; Manns MP; Sulkowski MS; Jacobson IM; Reddy KR; Goodman ZD; Boparai N
• Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial.
  Hepatology Volume: 46 Page(s): 971 - 981
  10/01/2007 Authors: Jacobson IM; Brown RS; Freilich B; Afdhal N; Kwo PY; Santoro J; Becker S; Wakil AE; Pound D; Godofsky E
• Prospective analysis of sustained virologic response (SVR) to PEG-interferon (PEG IFN) alfa-2b and ribavirin treatment in Asian and Hispanic patients with chronic hepatitis C: Results from the WIN-R trial
  Volume: 44 Page(s): 320A - 321A
  10/01/2006 Authors: Freilich B; Hu K-Q; Jacobson I; Brown R; Afdhal N; Kwo P; Santoro J; Becker S; Wakil A; Pound D
• Prior HCV treatment experience and its relationship to sustained virologic response (SVR): An analysis of the Win-R study database, a US academic community based trial
  Volume: 130 Page(s): A836 - A837
  04/01/2006 Authors: Kwo P; Jacobson IM; Brown RS; Freilich B; Afdhal B; Santoro J; Becker S; Wakil A; Pound D; Godofsky E
• Weight-based ribavirin dosing (WBD) increases sustained viral response (SVR) in patients with chronic hepatitis C (CHC): Final results of the WIN-R study, a US community based trial
  Volume: 42 Page(s): 749A - 749A
  10/01/2005 Authors: Jacobson IM; Brown RS; Freilich B; Afdhal N; Kwo P; Santoro J; Becker S; Wakil A; Pound D; Godofsky E
• The target trial: Final results using 3.0 mu g/kg pegylated interferon alfa 2-b (Peg;Peg-intron (R)) plus ribavirin (RBV;rebetol (R)) for chronic hepatitis C patients who were non-responders (NR) and relapsers (R) to previous therapy.
  Volume: 42 Page(s): 651A - 651A
  10/01/2005 Authors: White C; Wentworth C; Malet P; Lee W; Cantu V; Orellana M; Strauss R
• Serious ophthalmologic events during pegylated interferon and ribavirin therapy for chronic hepatitis C: Observations from the WIN-R Trial.
  Volume: 38 Page(s): 734A - 735A
  10/01/2003 Authors: Ahmed F; Jacobson IM; Chen ST; Cofrancesco S; Cooley J; Demicco M; Freilich B; Hudes B; Jensen J; Levin A
• Galanin immunoreactivity in paragangliomas but not in carcinoid tumors.
  Appl Immunohistochem Mol Morphol Volume: 11 Page(s): 250 - 252
  09/01/2003 Authors: Tadros TS; Strauss RM; Cohen C; Gal AA
• Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
  Bone Marrow Transplant Volume: 27 Page(s): 635 - 639
  03/01/2001 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
• Higher male prevalence of Helicobacter pylori associated hypertrophic gastritis is explained by tobacco and alcohol use.
  Volume: 118 Page(s): A1236 - A1236
  04/01/2000 Authors: Fukushima T; Strauss RM; Waring JP
• Selected drug complications and treatment conflicts in the presence of coexistent diseases.
  Rheum Dis Clin North Am Volume: 25 Page(s): 745 - x
  08/01/1999 Authors: Vassilopoulos D; Camisa C; Strauss RM
• Gastric cancer screening by radiography in Japanese adults residing in the USA.
  Volume: 116 Page(s): A409 - A409
  04/01/1999 Authors: Fukushima T; Torres WE; Waring JP; Strauss RM
• Dietary intake of fat does not influence colonic levels of glutathione-S transferase (GST) & NAD(P)H: Quinone-reductase (QR).
  Volume: 114 Page(s): A686 - A687
  04/15/1998 Authors: Tandon K; Goodrich MA; Wenger J; DeLong MJ; Strauss RM
• Transjugular intrahepatic portasystemic shunt (TIPS) for refractory hepatic hydrothorax (HHT) - Good for the lungs, not so good for the liver.
  Volume: 26 Page(s): 630 - 630
  10/01/1997 Authors: Chalasani N; Martin LG; Strauss RM; Boyer TD
• Serial measurement of serum hyaluronic acid in veno-occlusive disease (VOD) following bone marrow transplantation (BMT): Correlation with severity
  HEPATOLOGY Volume: 26 Page(s): 82 - 82
  10/01/1997 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Strauss RM; Boyer TD; McDonald GB
• Hepatic hydrothorax.
  Semin Liver Dis Volume: 17 Page(s): 227 - 232
  01/01/1997 Authors: Strauss RM; Boyer TD
• Serum hyaluronic acid as a marker of liver injury in venoocclusive disease (VOD) following bone marrow transplantation (BMT).
  HEPATOLOGY Volume: 24 Page(s): 1355 - 1355
  10/01/1996 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Ruocco C; Strauss RM; Boyer TD
• CHRONIC HEPATITIS-C IN HEMODIALYSIS (HD) PATIENTS - HISTOPATHOLOGY AND QUANTITATION OF HCV-RNA
  Volume: 20 Page(s): A404 - A404
  10/01/1994 Authors: STRAUSS RM; GITLIN N; CAUDILL M; NOLTE FS; BOYER TD
• FACTORS ASSOCIATED WITH NEED FOR LIVER-TRANSPLANTATION IN YOUNG-PATIENTS WITH HEPATITIS-C VIRAL-INFECTION
  Volume: 20 Page(s): A131 - A131
  10/01/1994 Authors: FRIED MW; NELSON N; TEDESCHI V; NOLTE FS; STRAUSS RM; GITLIN N; STIEBER AC; GORDON RD; BOYER TD
• Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.
  Am J Gastroenterol Volume: 89 Page(s): 1520 - 1522
  09/01/1994 Authors: Strauss RM; Martin LG; Kaufman SL; Boyer TD
• EFFECTIVENESS OF ETHANOL ABLATION THERAPY (PEAT) IN TREATING HEPATOCELLULAR-CARCINOMA (HCC) - IMPORTANCE OF FOLLOW-UP BIOPSY
  HEPATOLOGY Volume: 18 Page(s): A182 - A182
  10/01/1993 Authors: CHEZMAR JL; REDVANLY RD; NAGEL HS; STRAUSS RM; GALLOWAY JR; BOYER TD; BERNARDINO ME
• CHRONIC HEPATITIS-C - A CONTRAINDICATION TO RENAL-TRANSPLANTATION
  Volume: 18 Page(s): A344 - A344
  10/01/1993 Authors: STRAUSS RM; GITLIN N; CAUDILL M; NEYLAN JF; NOLTE FS; WHELCHEL JD; BOYER TD
• IS HUMAN BREAST-MILK A SOURCE OF HEPATITIS-C VIRUS (HCV)
  Volume: 18 Page(s): A257 - A257
  10/01/1993 Authors: STRAUSS RM; NOLTE FS; BOYER TD
• Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy.
  Radiology Volume: 188 Page(s): 283 - 285
  07/01/1993 Authors: Redvanly RD; Chezmar JL; Strauss RM; Galloway JR; Boyer TD; Bernardino ME
• GALANIN IMMUNOREACTIVITY - DIFFERENCES BETWEEN CARCINOID-TUMORS AND PARAGANGLIOMAS
  GASTROENTEROLOGY Volume: 104 Page(s): A856 - A856
  04/01/1993 Authors: STRAUSS RM; GAL AA; DEROSE PB; COHEN C
• IS ROUTINE ASCITIC FLUID CELL COUNT NECESSARY IN ASYMPTOMATIC OUT-PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS
  Volume: 104 Page(s): A887 - A887
  04/01/1993 Authors: CHALASANI N; SEEFF LC; STRAUSS RM
• The optimal interval for endoscopic variceal ligation with low-dose sclerotherapy.
  Gastrointest Endosc Volume: 39 Page(s): 211 - 212
  01/01/1993 Authors: Magod ME; Strauss RM; Waring JP
• ROLE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) IN THE PRIMARY MANAGEMENT OF REFRACTORY CIRRHOTIC HYDROTHORAX
  HEPATOLOGY Volume: 16 Page(s): A85 - A85
  10/01/1992 Authors: STRAUSS RM; MARTIN LG; KAUFMAN SL; GALLOWAY JR; WARING JP; BOYER TD
• HEPATITIS-C IN PATIENTS AWAITING RENAL-TRANSPLANTATION - THE SIGNIFICANCE OF A POSITIVE TEST FOR ANTI-HCV ANTIBODY
  Volume: 16 Page(s): A197 - A197
  10/01/1992 Authors: BOYER TD; STRAUSS RM; NEYLAN J; EMMENS RK; NOLTE FS; WHELCHEL J
• Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
  Volume: 138 Page(s): 897 - 909
  04/01/1991 Authors: Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
• Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy.
  Am J Med Volume: 89 Page(s): 464 - 469
  10/01/1990 Authors: Strauss RM; Wang TC; Kelsey PB; Compton CC; Ferraro MJ; Perez-Perez G; Parsonnet J; Blaser MJ
• Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.
  Cancer Res Volume: 49 Page(s): 3392 - 3395
  06/15/1989 Authors: Gattoni-Celli S; Strauss RM; Willett CG; Pozzatti R; Isselbacher KJ
• Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).
  Proc Natl Acad Sci U S A Volume: 85 Page(s): 8543 - 8547
  11/01/1988 Authors: Gattoni-Celli S; Willett CG; Rhoads DB; Simon B; Strauss RM; Kirsch K; Isselbacher KJ
• Simple microbiologic detection of Campylobacter pylori.
  J Clin Microbiol Volume: 26 Page(s): 948 - 949
  05/01/1988 Authors: Parsonnet J; Welch K; Compton C; Strauss R; Wang T; Kelsey P; Ferraro MJ
• THE CLINICAL-SIGNIFICANCE OF CAMPYLOBACTER PYLORI AND THE IMPORTANCE OF FUNDAL BIOPSIES
  Volume: 94 Page(s): A447 - A447
  05/01/1988 Authors: STRAUSS RM; WANG TC; KELSEY PB; FERRARO MJ; COMPTON CC